Cancer Immunology – Products

Terumo BCT and KBIOHealth have signed an MOU to develop workforce training for cell and gene therapy manufacturing in Korea. The program will focus on CAR-T and MSC therapy production using automated systems like Quantum Flex.

This application note introduces cytokines and their role in immunotherapy, outlines the key strategies employed in the development of next-generation cytokines, and presents the challenges and future directions

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.

We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening kits, stable cell lines, and PK assay kits for quantitative analysis.

This application focus explores how high-plex spatial profiling can be applied to better understand the role of T cells in cancer immune surveillance and how cancers evade the immune system.

This whitepaper discusses the classification of bsAbs targeting immunomodulatory checkpoints and highlights their applications in cancer immunotherapy.

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.

Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.

Transgene and ProBioGen, announce that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX® suspension cell line.

Top line data show that the randomized Phase II study of TG4001 in combination with avelumab versus avelumab in patients with recurrent or metastatic HPV16-positive cervical and anogenital tumors did not meet the primary objective of improvement.